Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects

A pilot study

Airani Sathananthan, Chiara Dalla Man, Francesco Micheletto, Alan R. Zinsmeister, Michael Camilleri, Paula D. Giesler, Jeanette M. Laugen, Gianna Toffolo, Robert A. Rizza, Claudio Cobelli, Adrian Vella

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

OBJECTIVE - Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects. RESEARCH DESIGN AND METHODS - Eighty-eight healthy individuals (aged 26.3 ± 0.6 years, fasting glucose 4.83 ± 0.04 mmol/l) were studied using a hyperglycemic clamp. GLP-1 was infused for the last 2 h of the study (0.75 pmol/kg/min over 121-180 min, 1.5 pmol/kg/min over 181-240 min). β-Cell responsivity (ΦTotal) was measured using a C-peptide minimal model. The effect of 21 tag single nucleotide polymorphisms (SNPs) in GLP1R on ΦTotal was examined. RESULTS - Two SNPs (rs6923761 and rs3765467) were nominally associated with altered β-cell responsivity in response to GLP-1 infusion. CONCLUSIONS - Variation in GLP1R may alter insulin secretion in response to exogenous GLP-1. Future studies will determine whether such variation accounts for interindividual differences in response to GLP-1-based therapy.

Original languageEnglish (US)
Pages (from-to)2074-2076
Number of pages3
JournalDiabetes Care
Volume33
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Glucagon-Like Peptide 1
Insulin
Single Nucleotide Polymorphism
C-Peptide
Hyperglycemia
Fasting
Research Design
Glucose

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Advanced and Specialized Nursing

Cite this

Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects : A pilot study. / Sathananthan, Airani; Dalla Man, Chiara; Micheletto, Francesco; Zinsmeister, Alan R.; Camilleri, Michael; Giesler, Paula D.; Laugen, Jeanette M.; Toffolo, Gianna; Rizza, Robert A.; Cobelli, Claudio; Vella, Adrian.

In: Diabetes Care, Vol. 33, No. 9, 09.2010, p. 2074-2076.

Research output: Contribution to journalArticle

Sathananthan, A, Dalla Man, C, Micheletto, F, Zinsmeister, AR, Camilleri, M, Giesler, PD, Laugen, JM, Toffolo, G, Rizza, RA, Cobelli, C & Vella, A 2010, 'Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: A pilot study', Diabetes Care, vol. 33, no. 9, pp. 2074-2076. https://doi.org/10.2337/dc10-0200
Sathananthan, Airani ; Dalla Man, Chiara ; Micheletto, Francesco ; Zinsmeister, Alan R. ; Camilleri, Michael ; Giesler, Paula D. ; Laugen, Jeanette M. ; Toffolo, Gianna ; Rizza, Robert A. ; Cobelli, Claudio ; Vella, Adrian. / Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects : A pilot study. In: Diabetes Care. 2010 ; Vol. 33, No. 9. pp. 2074-2076.
@article{96b9d5f7bfd341738057c7b889aedec3,
title = "Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: A pilot study",
abstract = "OBJECTIVE - Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects. RESEARCH DESIGN AND METHODS - Eighty-eight healthy individuals (aged 26.3 ± 0.6 years, fasting glucose 4.83 ± 0.04 mmol/l) were studied using a hyperglycemic clamp. GLP-1 was infused for the last 2 h of the study (0.75 pmol/kg/min over 121-180 min, 1.5 pmol/kg/min over 181-240 min). β-Cell responsivity (ΦTotal) was measured using a C-peptide minimal model. The effect of 21 tag single nucleotide polymorphisms (SNPs) in GLP1R on ΦTotal was examined. RESULTS - Two SNPs (rs6923761 and rs3765467) were nominally associated with altered β-cell responsivity in response to GLP-1 infusion. CONCLUSIONS - Variation in GLP1R may alter insulin secretion in response to exogenous GLP-1. Future studies will determine whether such variation accounts for interindividual differences in response to GLP-1-based therapy.",
author = "Airani Sathananthan and {Dalla Man}, Chiara and Francesco Micheletto and Zinsmeister, {Alan R.} and Michael Camilleri and Giesler, {Paula D.} and Laugen, {Jeanette M.} and Gianna Toffolo and Rizza, {Robert A.} and Claudio Cobelli and Adrian Vella",
year = "2010",
month = "9",
doi = "10.2337/dc10-0200",
language = "English (US)",
volume = "33",
pages = "2074--2076",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects

T2 - A pilot study

AU - Sathananthan, Airani

AU - Dalla Man, Chiara

AU - Micheletto, Francesco

AU - Zinsmeister, Alan R.

AU - Camilleri, Michael

AU - Giesler, Paula D.

AU - Laugen, Jeanette M.

AU - Toffolo, Gianna

AU - Rizza, Robert A.

AU - Cobelli, Claudio

AU - Vella, Adrian

PY - 2010/9

Y1 - 2010/9

N2 - OBJECTIVE - Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects. RESEARCH DESIGN AND METHODS - Eighty-eight healthy individuals (aged 26.3 ± 0.6 years, fasting glucose 4.83 ± 0.04 mmol/l) were studied using a hyperglycemic clamp. GLP-1 was infused for the last 2 h of the study (0.75 pmol/kg/min over 121-180 min, 1.5 pmol/kg/min over 181-240 min). β-Cell responsivity (ΦTotal) was measured using a C-peptide minimal model. The effect of 21 tag single nucleotide polymorphisms (SNPs) in GLP1R on ΦTotal was examined. RESULTS - Two SNPs (rs6923761 and rs3765467) were nominally associated with altered β-cell responsivity in response to GLP-1 infusion. CONCLUSIONS - Variation in GLP1R may alter insulin secretion in response to exogenous GLP-1. Future studies will determine whether such variation accounts for interindividual differences in response to GLP-1-based therapy.

AB - OBJECTIVE - Glucagon-like peptide (GLP)-1 receptor is encoded by GLP1R. The effect of genetic variation at this locus on the response to GLP-1 is unknown. This study assessed the effect of GLP1R polymorphisms on insulin secretion in response to hyperglycemia and to infused GLP-1 in nondiabetic subjects. RESEARCH DESIGN AND METHODS - Eighty-eight healthy individuals (aged 26.3 ± 0.6 years, fasting glucose 4.83 ± 0.04 mmol/l) were studied using a hyperglycemic clamp. GLP-1 was infused for the last 2 h of the study (0.75 pmol/kg/min over 121-180 min, 1.5 pmol/kg/min over 181-240 min). β-Cell responsivity (ΦTotal) was measured using a C-peptide minimal model. The effect of 21 tag single nucleotide polymorphisms (SNPs) in GLP1R on ΦTotal was examined. RESULTS - Two SNPs (rs6923761 and rs3765467) were nominally associated with altered β-cell responsivity in response to GLP-1 infusion. CONCLUSIONS - Variation in GLP1R may alter insulin secretion in response to exogenous GLP-1. Future studies will determine whether such variation accounts for interindividual differences in response to GLP-1-based therapy.

UR - http://www.scopus.com/inward/record.url?scp=78650890818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650890818&partnerID=8YFLogxK

U2 - 10.2337/dc10-0200

DO - 10.2337/dc10-0200

M3 - Article

VL - 33

SP - 2074

EP - 2076

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 9

ER -